NASDAQ:PRTO - Proteon Therapeutics News Headlines

Sign in or create an account to add this stock to your watchlist.
$2.99 +0.02 (+0.67 %)
(As of 02/15/2019 04:00 PM ET)
Previous Close$2.99
Today's Range$2.96 - $3.05
52-Week Range$1.50 - $3.10
Volume214,558 shs
Average Volume108,639 shs
Market Capitalization$57.47 million
P/E Ratio-1.40
Dividend YieldN/A
Beta0.77

Headlines

Proteon Therapeutics (NASDAQ PRTO) News Headlines

Source:
DateHeadline
Proteon Therapeutics Inc (PRTO) Receives Consensus Recommendation of "Buy" from BrokeragesProteon Therapeutics Inc (PRTO) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - February 12 at 3:21 PM
Proteon Therapeutics Inc (PRTO) Expected to Post Earnings of -$0.25 Per ShareProteon Therapeutics Inc (PRTO) Expected to Post Earnings of -$0.25 Per Share
www.americanbankingnews.com - February 11 at 7:14 PM
Contrasting Outlook Therapeutics (OTLK) and Proteon Therapeutics (PRTO)Contrasting Outlook Therapeutics (OTLK) and Proteon Therapeutics (PRTO)
www.americanbankingnews.com - February 11 at 11:22 AM
Proteon Therapeutics (PRTO) Upgraded at JMP SecuritiesProteon Therapeutics (PRTO) Upgraded at JMP Securities
www.americanbankingnews.com - February 11 at 10:00 AM
Reviewing DBV TECHNOLOGIE/S (DBVT) & Proteon Therapeutics (PRTO)Reviewing DBV TECHNOLOGIE/S (DBVT) & Proteon Therapeutics (PRTO)
www.americanbankingnews.com - February 7 at 5:24 AM
HC Wainwright Analysts Give Proteon Therapeutics (PRTO) a $3.00 Price TargetHC Wainwright Analysts Give Proteon Therapeutics (PRTO) a $3.00 Price Target
www.americanbankingnews.com - January 28 at 12:20 AM
Proteon down 3%Proteon down 3%
seekingalpha.com - January 24 at 5:45 PM
Results supported the design of ongoing pivotal study and FDA Breakthrough Therapy designationResults supported the design of ongoing pivotal study and FDA Breakthrough Therapy designation
globenewswire.com - January 24 at 9:20 AM
Proteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with Chronic Kidney DiseaseProteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with Chronic Kidney Disease
finance.yahoo.com - January 24 at 9:20 AM
Does The Proteon Therapeutics, Inc. (NASDAQ:PRTO) Share Price Fall With The Market?Does The Proteon Therapeutics, Inc. (NASDAQ:PRTO) Share Price Fall With The Market?
finance.yahoo.com - December 20 at 4:58 PM
Proteon Therapeutics to Present at the Stifel 2018 Healthcare Conference November 13thProteon Therapeutics to Present at the Stifel 2018 Healthcare Conference November 13th
finance.yahoo.com - November 8 at 9:11 AM
Proteon Therapeutics: 3Q Earnings SnapshotProteon Therapeutics: 3Q Earnings Snapshot
finance.yahoo.com - November 7 at 4:57 PM
BRIEF-Proteon Therapeutics reports third quarter resultsBRIEF-Proteon Therapeutics reports third quarter results
www.msn.com - November 7 at 9:15 AM
Proteon Therapeutics Announces Third Quarter 2018 Financial ResultsProteon Therapeutics Announces Third Quarter 2018 Financial Results
finance.yahoo.com - November 7 at 9:15 AM
Is Proteon Therapeutics Inc (NASDAQ:PRTO) A Strong Healthcare Bet?Is Proteon Therapeutics Inc (NASDAQ:PRTO) A Strong Healthcare Bet?
finance.yahoo.com - September 17 at 4:43 PM
Proteon Therapeutics Announces Second Quarter 2018 Financial ResultsProteon Therapeutics Announces Second Quarter 2018 Financial Results
finance.yahoo.com - August 7 at 9:26 AM
Proteon Therapeutics: 2Q Earnings SnapshotProteon Therapeutics: 2Q Earnings Snapshot
finance.yahoo.com - August 7 at 9:26 AM
Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 21stProteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 21st
globenewswire.com - June 14 at 9:08 AM
Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 21stProteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 21st
finance.yahoo.com - June 14 at 9:08 AM
Reader Inquiry: Is Proteon Therapeutics Still A Buy?Reader Inquiry: Is Proteon Therapeutics Still A Buy?
seekingalpha.com - June 11 at 4:40 PM
Proteon Therapeutics Inc’s (NASDAQ:PRTO) Earnings Dropped -27.47%, How Did It Fare Against The Industry?Proteon Therapeutics Inc’s (NASDAQ:PRTO) Earnings Dropped -27.47%, How Did It Fare Against The Industry?
finance.yahoo.com - May 16 at 9:27 AM
UPDATE: H.C. Wainwright Upgrades Proteon Therapeutics (PRTO) to BuyUPDATE: H.C. Wainwright Upgrades Proteon Therapeutics (PRTO) to Buy
www.streetinsider.com - May 12 at 9:50 AM
Proteon Therapeutics Announces First Quarter 2018 Financial ResultsProteon Therapeutics Announces First Quarter 2018 Financial Results
finance.yahoo.com - May 9 at 9:17 AM
Proteon Therapeutics: 1Q Earnings SnapshotProteon Therapeutics: 1Q Earnings Snapshot
finance.yahoo.com - May 9 at 9:17 AM
Proteon Therapeutics and Lonza Extend Manufacturing Agreement for Commercial SupplyProteon Therapeutics and Lonza Extend Manufacturing Agreement for Commercial Supply
finance.yahoo.com - May 8 at 9:10 AM
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2017 Financial ResultsProteon Therapeutics Announces Fourth Quarter and Full-Year 2017 Financial Results
finance.yahoo.com - March 14 at 10:10 AM
Proteon Therapeutics Inc (NASDAQ:PRTO): Are Analysts Optimistic?Proteon Therapeutics Inc (NASDAQ:PRTO): Are Analysts Optimistic?
finance.yahoo.com - March 14 at 10:10 AM
Proteon Therapeutics Completes Enrollment in PATENCY-2, Phase 3 Clinical Trial of Investigational VonapanitaseProteon Therapeutics Completes Enrollment in PATENCY-2, Phase 3 Clinical Trial of Investigational Vonapanitase
finance.yahoo.com - March 5 at 5:10 PM
Proteon Therapeutics to Present at the Stifel 2017 Healthcare Conference November 15thProteon Therapeutics to Present at the Stifel 2017 Healthcare Conference November 15th
finance.yahoo.com - November 9 at 11:56 AM
Proteon Therapeutics Announces Third Quarter 2017 Financial ResultsProteon Therapeutics Announces Third Quarter 2017 Financial Results
finance.yahoo.com - November 7 at 9:03 AM
Proteon Therapeutics reports 3Q lossProteon Therapeutics reports 3Q loss
finance.yahoo.com - November 7 at 9:03 AM
Proteon Therapeutics to Present at the Baird 2017 Global Healthcare Conference September 7, 2017Proteon Therapeutics to Present at the Baird 2017 Global Healthcare Conference September 7, 2017
finance.yahoo.com - September 6 at 7:28 AM
Proteon Therapeutics Announces Second Quarter 2017 Financial ResultsProteon Therapeutics Announces Second Quarter 2017 Financial Results
finance.yahoo.com - August 8 at 6:22 AM
Proteon Therapeutics Announces Closing of $22 Million Convertible Preferred Stock FinancingProteon Therapeutics Announces Closing of $22 Million Convertible Preferred Stock Financing
finance.yahoo.com - August 3 at 7:06 AM
Proteon Therapeutics Announces First Quarter 2017 Financial ResultsProteon Therapeutics Announces First Quarter 2017 Financial Results
globenewswire.com - May 10 at 7:33 PM
Pre-Open Stock Movers 05/10: (PRTO) (NVDA) (INCR) Higher; (YELP) (VSI) (FOSL) Lower (more...)Pre-Open Stock Movers 05/10: (PRTO) (NVDA) (INCR) Higher; (YELP) (VSI) (FOSL) Lower (more...)
www.streetinsider.com - May 10 at 11:29 AM
Proteon Therapeutics Receives FDA Breakthrough Therapy Designation for VonapanitaseProteon Therapeutics Receives FDA Breakthrough Therapy Designation for Vonapanitase
www.nasdaq.com - May 10 at 11:29 AM
Proteon Therapeutics reports 1Q lossProteon Therapeutics reports 1Q loss
marketbeat.com - May 10 at 8:13 AM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible ... - Business Wire (press release)SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible ... - Business Wire (press release)
www.businesswire.com - March 24 at 8:16 AM
PROTEON THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsPROTEON THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
biz.yahoo.com - March 22 at 7:30 AM
Proteon Therapeutics (PRTO) Management Discuses Changes to the Ongoing Phase 3 PATENCY-2 Clinical Trial ... - Seeking AlphaProteon Therapeutics' (PRTO) Management Discuses Changes to the Ongoing Phase 3 PATENCY-2 Clinical Trial ... - Seeking Alpha
seekingalpha.com - March 17 at 7:28 PM
Proteon CEO: New trial could be a path to marketProteon CEO: New trial could be a path to market
www.bizjournals.com - March 17 at 7:28 PM
PROTEON THERAPEUTICS INC Files SEC form 10-K, Annual ReportPROTEON THERAPEUTICS INC Files SEC form 10-K, Annual Report
us.rd.yahoo.com - March 16 at 8:07 PM
PROTEON THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,PROTEON THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,
us.rd.yahoo.com - March 16 at 8:07 PM
Form 8-K PROTEON THERAPEUTICS For: Mar 16 - StreetInsider.comForm 8-K PROTEON THERAPEUTICS For: Mar 16 - StreetInsider.com
www.streetinsider.com - March 16 at 8:26 AM
Proteon Therapeutics (PRTO) Announces Two Presentations at ASDIN MeetingProteon Therapeutics (PRTO) Announces Two Presentations at ASDIN Meeting
www.streetinsider.com - February 6 at 7:26 PM
Proteon Therapeutics Inc. (PRTN) Has Plunged To A New Low After Study FailedProteon Therapeutics Inc. (PRTN) Has Plunged To A New Low After Study Failed
www.rttnews.com - December 14 at 8:09 PM
Failure in late clinical trial pummels Proteon Therapeutics stockFailure in late clinical trial pummels Proteon Therapeutics stock
www.bizjournals.com - December 14 at 8:09 PM
7:00 am Proteon Therapeutics announces that its first Phase 3 clinical trial with investigational vonapanitase did not meet its primary endpoint of improved primary unassisted patency compared to placebo (shares halted)7:00 am Proteon Therapeutics announces that its first Phase 3 clinical trial with investigational vonapanitase did not meet its primary endpoint of improved primary unassisted patency compared to placebo (shares halted)
us.rd.yahoo.com - December 13 at 7:43 PM
Waltham biotechs shares tank after kidney disease drug flunks trialWaltham biotech's shares tank after kidney disease drug flunks trial
us.rd.yahoo.com - December 13 at 7:43 PM
This page was last updated on 2/16/2019 by MarketBeat.com Staff

Featured Article: Growth Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel